SeQuent Scientific and Viyash Lifesciences have announced a strategic merger aimed at establishing a leadership position in the global animal health market. By combining their strengths, the two companies will enhance R&D capabilities, expand manufacturing resources, and improve service delivery, creating a robust platform for innovation and growth. This merger marks a pivotal moment in the industry, positioning the combined entity to better serve customer needs and capitalize on emerging market opportunities.